Abel Hall, LLC Corcept Therapeutics Inc Transaction History
Abel Hall, LLC
- $166 Billion
- Q1 2025
A detailed history of Abel Hall, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Abel Hall, LLC holds 2,082 shares of CORT stock, worth $153,943. This represents 0.14% of its overall portfolio holdings.
Number of Shares
2,082Holding current value
$153,943% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
439Shares Held
84.3MCall Options Held
1.04MPut Options Held
1.33M-
Black Rock Inc. New York, NY16.5MShares$1.22 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$748 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$599 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$458 Million0.49% of portfolio
-
Parallel Advisors, LLC3.97MShares$294 Million5.04% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.92B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...